Table 3.
Rate of relapse, in-field recurrence, and survival by histological outcome of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) at a median follow-up of 36 mo
| PC-RPLND histology | N | Positive surgical margin (%) | Relapses (%) | In-field relapses (%) | Overall survival (%) |
|---|---|---|---|---|---|
| Benign/necrosis | 40 | 0 (0%) | 1 (2.5%) | 0 (0%) | 40 (100%) |
| TD | 98 | 7 (7.1%) | 11 (11.2%) | 2 (2.0%) | 97 (99.0%) |
| Viable GCT ± TD | 28 | 9 (32.1%) | 15 (53.6%) | 0 (0%) | 17 (60.1%) |
| Dedifferentiated malignancy | 7 | 4 (57.1%) | 4 (57.1%) | 2 (28.6%) | 4 (57.1%) |
| Inoperable | 4 | NA | NA | NA | 1 (25.0%) |
| Total | 178 | 20 (11.2%) | 31 (17.4%) | 4 (2.2%) | 159 (89.3%) |
GCT = germ cell tumour; NA = not available; TD = teratoma differentiated.